Literature DB >> 20534394

Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).

Nuria Rodríguez Salas1, Enrique González González, Carlos Gamallo Amat.   

Abstract

The cancer stem cells hypothesis arises from observation of normal tissue hierarchy and the demonstration of stem cells in normal tissues. Scientists continue to debate whether the putative cancer cells derive from the transformation of normal tissue stem cells or from more differentiated cells. The existence of a subpopulation of tumour cells with stem-cell-like characteristics, including very slow replication and resistance to standard chemotherapy, posses a novel therapeutic challenge. This review summarises the state of development of normal and cancer breast cells and the clinical and therapeutic relevance.

Entities:  

Mesh:

Year:  2010        PMID: 20534394     DOI: 10.1007/s12094-010-0526-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  33 in total

1.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

Authors:  Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 2.  The emerging picture of the mouse mammary stem cell.

Authors:  François Vaillant; Marie-Liesse Asselin-Labat; Mark Shackleton; Geoffrey J Lindeman; Jane E Visvader
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

Authors:  Charles R Holst; Gerard J Nuovo; Manel Esteller; Karen Chew; Stephen B Baylin; James G Herman; Thea D Tlsty
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

5.  Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

Authors:  Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Giovanni Mazzarol; Manuela Vecchi; Simona Ronzoni; Loris Bernard; Giuseppe Viale; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

6.  Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase.

Authors:  K D Bunting; R Lindahl; A J Townsend
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

7.  Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.

Authors:  Koji Morimoto; Seung Jin Kim; Tomonori Tanei; Kenzo Shimazu; Yoshio Tanji; Tetsuya Taguchi; Yasuhiro Tamaki; Nobuyuki Terada; Shinzaburo Noguchi
Journal:  Cancer Sci       Date:  2009-03-09       Impact factor: 6.716

8.  Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

Authors:  Tomonori Tanei; Koji Morimoto; Kenzo Shimazu; Seung Jin Kim; Yoshio Tanji; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

Review 9.  Differentiation of the mammary gland and susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

10.  Evidence for a stem cell hierarchy in the adult human breast.

Authors:  René Villadsen; Agla J Fridriksdottir; Lone Rønnov-Jessen; Thorarinn Gudjonsson; Fritz Rank; Mark A LaBarge; Mina J Bissell; Ole W Petersen
Journal:  J Cell Biol       Date:  2007-04-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.